Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-12-13

Clinical Trial Update: A Study of Topical NS2 Cream to Treat Ichthyosis in Sjögren-Larsson Syndrome (SLS) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial of Topical NS2 Cream for Sjögren-Larsson Syndrome has completed with results posted in 2022.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Topical NS2 Cream

Snippet

Sponsor: Aldeyra Therapeutics, Inc. | Conditions: Sjögren-Larsson Syndrome | Phase 2 | Status: COMPLETED | Results posted: 2022-12-13